News | Treatment Planning | October 27, 2016

New Netherlands proton therapy center will also be one of the world’s first clinics to use RayCare oncology information system

RaySearch Labs, RayStation treatment planning system, RayCare oncology information system, University Medical Center Groningen, UMCG, Netherlands, radiation therapy

October 27, 2016 — University Medical Center Groningen (UMCG) in the Netherlands has selected RayStation as its treatment planning system. RayStation will replace the hospital’s existing system for conventional (photon) radiation therapy and will be the treatment planning system for its new proton therapy center. UMCG will have 30 clinical and 16 development licenses in total.

UMCG’s new proton therapy center, currently under construction, will be equipped with IBA’s ProteusPlus two-gantry room configuration, including pencil beam scanning (PBS) and cone beam computed tomography (CT) capabilities. UMCG anticipates the center will treat around 600 patients per year, with the first treatments taking place end of 2017.

The RayStation installation will include adaptive radiation therapy, multi-criteria optimization and radiobiology. In addition, a cluster computing platform will provide optimized performance for the Plan Explorer feature in RayStation. Plan Explorer automatically generates a large number of high-quality treatment plan alternatives, saving time and giving the clinician a wide range of options to consider.

UMCG will also be one of the first clinics in the world to implement RayCare, the oncology information system currently in development at RaySearch. RayCare is designed to improve workflows across treatment techniques and to meet the demands of new techniques and approaches in cancer treatment.

Prof. Hans Langendijk, chair of the Department of Radiation Oncology at UMCG, said: “Advanced techniques such as adaptive therapy and proton therapy demand software solutions that are equally cutting-edge. We are a pioneer of radiation therapy in the Netherlands, and RaySearch is a partner that helps us improve treatment for all of our patients.”

For more information: www.raysearchlabs.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now